德普伊合成公司推出VELYSTM SPINE,这是其首个活跃的脊柱机器人平台,经FDA批准用于脊柱融合手术. DePuy Synthes launches VELYS™ SPINE, its first active spine robotics platform, FDA-cleared for spinal fusion procedures.

Johnson & Johnson的DePuy合成公司已经启动了VELYSTM SPINE,这是其第一个活跃的脊椎机器人和导航平台,旨在规划和测量脊髓融合程序。 Johnson & Johnson's DePuy Synthes has launched the VELYS™ SPINE, its first active spine robotics and navigation platform, designed for planning and instrumenting spinal fusion procedures. 经FDA批准的双用途系统提供了可定制的体验,具有病理学特定的工作流程和活跃的机器人,为外科医生提供量身定制的手术指导. The dual-use system, cleared by the FDA, offers customizable experiences with pathology-specific workflows and active robotics, enabling tailored surgical guidance for surgeons. 它将与DePuy合成脊柱产品相结合,并在2025年H1市场上提供。 It will integrate with DePuy Synthes Spine products and be commercially available in H1 2025.